Atara Biotherapeutics (ATRA) PT Lowered to $16 at Stifel on Bayer Deal Pull Out, Reiterates Focus on ATA188
Tweet Send to a Friend
Stifel analyst Benjamin Burnett lowered the price target on Atara Biotherapeutics (NASDAQ: ATRA) to $16.00 (from $18.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
